BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

by American Association for Cancer ResearchGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Dabrafenib (Tafinlar), a BRAF inhibitor approve

Updated on: March 30,2024 17

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

by American Association for Cancer ResearchGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Dabrafenib (Tafinlar), a BRAF inhibitor approve

Updated on:March 30,2024 17

Routine screening for pancreatic cancer not warranted, expert panel says

(HealthDay)—There's nothing to be gained by screening for pancreatic cancer in people with no signs or symptoms of the lethal tumor, according to an influential U.S. panel of experts.Looking over

Updated on: April 01,2024 13

Routine screening for pancreatic cancer not warranted, expert panel says

(HealthDay)—There's nothing to be gained by screening for pancreatic cancer in people with no signs or symptoms of the lethal tumor, according to an influential U.S. panel of experts.Looking over

Updated on:April 01,2024 13

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C

Updated on: July 17,2024 0

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C

Updated on:July 17,2024 0

Novel approach to study hypoxia enables identification of a marker for ovarian cancers

by Myreille Larouche,University of MontrealLong-term severe hypoxia adaptation induces EMT-like morphological changes. Credit:Cancer Gene Therapy(2024). DOI: 10.1038/s41417-024-00795

Updated on: August 28,2024 0

Novel approach to study hypoxia enables identification of a marker for ovarian cancers

by Myreille Larouche,University of MontrealLong-term severe hypoxia adaptation induces EMT-like morphological changes. Credit:Cancer Gene Therapy(2024). DOI: 10.1038/s41417-024-00795

Updated on:August 28,2024 0

Enzyme that helps protect us from stress linked to liver cancer growth

by Medical College of Georgia at Augusta UniversityDr. Satya Ande, molecular biologist in the MCG Department of Biochemistry and Molecular Biology and Georgia Cancer Center and MCG postdoctoral f

Updated on: April 14,2024 10

Enzyme that helps protect us from stress linked to liver cancer growth

by Medical College of Georgia at Augusta UniversityDr. Satya Ande, molecular biologist in the MCG Department of Biochemistry and Molecular Biology and Georgia Cancer Center and MCG postdoctoral f

Updated on:April 14,2024 10

Study identifies a genetic driver of deadly prostate cancer

by Cedars-Sinai Medical CenterGraph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone thera

Updated on: March 12,2024 19

Study identifies a genetic driver of deadly prostate cancer

by Cedars-Sinai Medical CenterGraph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone thera

Updated on:March 12,2024 19

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on: January 30,2024 13

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on:January 30,2024 13

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'

Updated on: March 06,2024 17

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'

Updated on:March 06,2024 17

Cancer survivors predicted to number over 22 million by 2030

by American Cancer SocietyCredit: CC0 Public DomainThere were more than 16.9 million Americans with a history of cancer on January 1, 2019, a number that is projected to reach more than 22.1 mill

Updated on: March 06,2024 20

Cancer survivors predicted to number over 22 million by 2030

by American Cancer SocietyCredit: CC0 Public DomainThere were more than 16.9 million Americans with a history of cancer on January 1, 2019, a number that is projected to reach more than 22.1 mill

Updated on:March 06,2024 20

Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

by Luisa Hoffmann,Helmholtz Association of German Research CentresCredit: Pixabay/CC0 Public DomainA research team at Helmholtz Munich has revealed a specific mechanism that is able to promote c

Updated on: January 30,2024 18

Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

by Luisa Hoffmann,Helmholtz Association of German Research CentresCredit: Pixabay/CC0 Public DomainA research team at Helmholtz Munich has revealed a specific mechanism that is able to promote c

Updated on:January 30,2024 18

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on: September 27,2024 0

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on:September 27,2024 0

Family of DNA damage–inducing microbial metabolites found in guts of people with IBD

by Bob Yirka , Medical XpressHuman gut microbes isolated from IBD patients produce small-molecule genotoxins. Diverse gut microbes isolated from patients with IBD exhibit direct genotoxicity. M. morga

Updated on: February 03,2024 19

Family of DNA damage–inducing microbial metabolites found in guts of people with IBD

by Bob Yirka , Medical XpressHuman gut microbes isolated from IBD patients produce small-molecule genotoxins. Diverse gut microbes isolated from patients with IBD exhibit direct genotoxicity. M. morga

Updated on:February 03,2024 19